Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Stimulant Use & Co-occuring Opioid Use Disorders
and you are
over 18
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study will investigate the effects of intranasal administration of oxytocin, a social neuropeptide, on reducing stimulant use, enhancing therapeutic engagement, and susceptibility to stress-induced relapse in Veterans with stimulant use disorders and enrolled in opioid replacement therapy (ORT) program for co-occurring opioid use disorder (OUD).

Provided treatments

  • Drug: Intranasal oxytocin
  • Drug: Intranasal placebo
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03016598. The sponsor of the trial is VA Office of Research and Development and it is looking for 50 volunteers for the current phase.
Official trial title:
6-week Trial of Oxytocin for Co-occurring Cocaine and Opioid Use Disorders